secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001193125-25-200715
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus raises ~$270M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Issued 6,487,879 common shares at $33.00/share and 1,112,121 pre-funded warrants at $32.999/share.
- Underwriters exercised in full option for additional 1,140,000 shares.
- Net proceeds expected to be approximately $270 million after discounts and expenses.
- Offering priced Sept 9, 2025; closing expected Sept 11, 2025.
- Pre-funded warrants exercisable at any time; beneficial ownership cap of 4.99%-19.99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000119312525200715/0001193125-25-200715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000119312525200715/d96557d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-200715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer